These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


56 related items for PubMed ID: 6299309

  • 21. Quantification of Delta9-tetrahydrocannabinol and its major metabolites in meconium by gas chromatographic-mass spectrometric assay: assay validation and preliminary results of the "meconium project".
    Marchei E, Pellegrini M, Pacifici R, Palmi I, Lozano J, García-Algar O, Pichini S.
    Ther Drug Monit; 2006 Oct; 28(5):700-6. PubMed ID: 17038890
    [Abstract] [Full Text] [Related]

  • 22. Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans.
    Hart CL, Ward AS, Haney M, Comer SD, Foltin RW, Fischman MW.
    Psychopharmacology (Berl); 2002 Dec; 164(4):407-15. PubMed ID: 12457271
    [Abstract] [Full Text] [Related]

  • 23. [Use of thin-layer chromatography for detection of 11-nor-9-carboxy-delta9-tetrahydrocannabinol in the urine].
    Nikonova EV, Karaeva LD.
    Sud Med Ekspert; 2005 Dec; 48(5):33-5. PubMed ID: 16279498
    [Abstract] [Full Text] [Related]

  • 24. Microsomal alcohol oxygenase: purification and characterization of a cytochrome P450 responsible for oxidation of 7-hydroxy-delta 8-tetrahydrocannabinol to 7-oxo-delta 8-tetrahydrocannabinol in guinea pig liver.
    Matsunaga T, Tanaka H, Komura A, Watanabe K, Yamamoto I, Yoshimura H.
    Arch Biochem Biophys; 1997 Dec 01; 348(1):56-64. PubMed ID: 9390174
    [Abstract] [Full Text] [Related]

  • 25. [Delta-9-tetrahydrocannabinol pharmacokinetics].
    Goullé JP, Saussereau E, Lacroix C.
    Ann Pharm Fr; 2008 Aug 01; 66(4):232-44. PubMed ID: 18847571
    [Abstract] [Full Text] [Related]

  • 26. Observation of reduced concentration of delta 9-THC-carboxylic acid in urine specimen containers using internal barcode labels.
    Bond GD, Chand P, Walia AS, Liu RH.
    J Anal Toxicol; 1990 Aug 01; 14(6):389-90. PubMed ID: 1964990
    [No Abstract] [Full Text] [Related]

  • 27. Simultaneous analysis of THC and its metabolites in blood using liquid chromatography-tandem mass spectrometry.
    Del Mar Ramirez Fernandez M, De Boeck G, Wood M, Lopez-Rivadulla M, Samyn N.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Nov 15; 875(2):465-70. PubMed ID: 18922747
    [Abstract] [Full Text] [Related]

  • 28. The effect of orally and rectally administered delta 9-tetrahydrocannabinol on spasticity: a pilot study with 2 patients.
    Brenneisen R, Egli A, Elsohly MA, Henn V, Spiess Y.
    Int J Clin Pharmacol Ther; 1996 Oct 15; 34(10):446-52. PubMed ID: 8897084
    [Abstract] [Full Text] [Related]

  • 29. Pharmacokinetic factors in sex differences in Delta 9-tetrahydrocannabinol-induced behavioral effects in rats.
    Tseng AH, Harding JW, Craft RM.
    Behav Brain Res; 2004 Sep 23; 154(1):77-83. PubMed ID: 15302113
    [Abstract] [Full Text] [Related]

  • 30. Pharmacokinetics of 11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol (CTHC) after intravenous administration of CTHC in healthy human subjects.
    Glaz-Sandberg A, Dietz L, Nguyen H, Oberwittler H, Aderjan R, Mikus G.
    Clin Pharmacol Ther; 2007 Jul 23; 82(1):63-9. PubMed ID: 17410118
    [Abstract] [Full Text] [Related]

  • 31. Identification in human urine of delta 9-tetrahydrocannabinol-11-oic acid glucuronide: a tetrahydrocannabinol metabolite.
    Williams PL, Moffat AC.
    J Pharm Pharmacol; 1980 Jul 23; 32(7):445-8. PubMed ID: 6105177
    [Abstract] [Full Text] [Related]

  • 32. Marihuana metabolites in urine of man. III. Unchanged delta-9-tetrahydrocannabinol.
    Hollister LE, Kanter SL, Board RD, Green DE.
    Res Commun Chem Pathol Pharmacol; 1974 Aug 23; 8(4):579-84. PubMed ID: 4420916
    [No Abstract] [Full Text] [Related]

  • 33. Metabolism and disposition of delta-9-tetrahydrocannabinol in man.
    Lemberger L, Axelrod J, Kopin IJ.
    Pharmacol Rev; 1971 Dec 23; 23(4):371-80. PubMed ID: 4943951
    [No Abstract] [Full Text] [Related]

  • 34. Cannabinol-7-oic acid: a metabolite of delta1-tetrahydrocannabinol in the rhesus monkey.
    Ben-Zvi Z, Bergen JR, Burstein S.
    Res Commun Chem Pathol Pharmacol; 1974 Sep 23; 9(1):201-4. PubMed ID: 4216059
    [No Abstract] [Full Text] [Related]

  • 35. [Detection of 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid in urine using thin-layer chromatography].
    Nováková E.
    Soud Lek; 1997 Feb 23; 42(1):5-8. PubMed ID: 9221514
    [Abstract] [Full Text] [Related]

  • 36. Plasma levels of delta 9-tetrahydrocannabinol after intravenous, oral, and smoke administration.
    Ohlsson A, Lindgren JE, Wahlen A, Agurell S, Hollister LE, Gillespie HK.
    NIDA Res Monogr; 1981 Feb 23; 34():250-6. PubMed ID: 6261133
    [No Abstract] [Full Text] [Related]

  • 37. Identification of a C-Glucuronide of Dgr6-Tetrahydrocannabinol as a Mouse Liver Conjugate in vivo.
    Levy S, Yagen B, Mechoulam R.
    Science; 1978 Jun 23; 200(4348):1391-2. PubMed ID: 17736323
    [Abstract] [Full Text] [Related]

  • 38. Marihuana: studies on the disposition and metabolism of delta-9-tetrahydrocannabinol in man.
    Lemberger L, Silberstein SD, Axelrod J, Kopin IJ.
    Science; 1970 Dec 18; 170(3964):1320-2. PubMed ID: 5479011
    [Abstract] [Full Text] [Related]

  • 39. Metabolite of (-)-trans-delta 8-tetrahydrocannabinol: identification and synthesis.
    Foltz RL, Fentiman AF, Leighty FG, Walter JL, Drewes HR, Schwartz WE, Page TF, Truitt EB.
    Science; 1970 May 15; 168(3933):844-5. PubMed ID: 5444059
    [Abstract] [Full Text] [Related]

  • 40. Subchronic ocular and systemic toxicity of topically applied delta 9-tetrahydrocannabinol.
    Green K, Sobel RE, Fineberg E, Wynn HR, Bowman KA.
    Ann Ophthalmol; 1981 Oct 15; 13(10):1219-22. PubMed ID: 6274239
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 3.